[HTML][HTML] ESCMID rapid guidelines for assessment and management of long COVID

D Yelin, CD Moschopoulos, I Margalit… - Clinical Microbiology …, 2022 - Elsevier
Scope The aim of these guidelines is to provide evidence-based recommendations for the
assessment and management of individuals with persistent symptoms after acute COVID-19 …

Interventions for the prevention of persistent post‐COVID‐19 olfactory dysfunction

KE Webster, L O'Byrne, S MacKeith… - Cochrane Database …, 2022 - cochranelibrary.com
Background Loss of olfactory function is well recognised as a symptom of COVID‐19
infection, and the pandemic has resulted in a large number of individuals with abnormalities …

Prednisolone does not improve olfactory function after COVID-19: a randomized, double-blind, placebo-controlled trial

EJA Schepens, EE Blijleven, WM Boek, S Boesveldt… - BMC medicine, 2022 - Springer
Background Prednisolone has been suggested as a treatment for olfactory disorders after
COVID-19, but evidence is scarce. Hence, we aimed to determine the efficacy of a short oral …

Post-COVID symptoms in occupational cohorts: effects on health and work ability

N Magnavita, G Arnesano, RR Di Prinzio… - International Journal of …, 2023 - mdpi.com
Post-acute COVID-19 syndrome is frequently observed in workers and has a substantial
impact on work ability. We conducted a health promotion program to identify cases of post …

Efficacy and safety of saline nasal irrigation plus theophylline for treatment of COVID-19–related olfactory dysfunction: the SCENT2 phase 2 randomized clinical trial

S Gupta, JJ Lee, A Perrin, A Khan… - … –Head & Neck …, 2022 - jamanetwork.com
Importance Recent studies suggest that theophylline added to saline nasal irrigation (SNI)
can be an effective treatment for postviral olfactory dysfunction (OD), a growing public health …

Incidence of post-COVID syndrome and associated symptoms in outpatient care in Bavaria, Germany: a retrospective cohort study using routinely collected claims …

E Donnachie, A Hapfelmeier, K Linde, M Tauscher… - BMJ open, 2022 - bmjopen.bmj.com
Objectives To estimate the treatment incidence of post-COVID syndrome (postinfectious
sequelae present at least 12 weeks following infection) in the context of ambulatory care in …

A comprehensive review of natural flavonoids with anti-SARS-CoV-2 activity

JY Yang, YX Ma, Y Liu, XJ Peng, XZ Chen - Molecules, 2023 - mdpi.com
The COVID-19 pandemic caused by SARS-CoV-2 has majorly impacted public health and
economies worldwide. Although several effective vaccines and drugs are now used to …

Post-COVID-19 anosmia and therapies: stay tuned for new drugs to sniff out

G Riccardi, GF Niccolini, MG Bellizzi, M Fiore, A Minni… - Diseases, 2023 - mdpi.com
Background: Anosmia is defined as the complete absence of olfactory function, which can
be caused by a variety of causes, with upper respiratory tract infections being among the …

Neurologic complications of coronavirus and other respiratory viral infections

F Cavallieri, J Sellner, M Zedde, E Moro - Handbook of clinical neurology, 2022 - Elsevier
In humans, several respiratory viruses can have neurologic implications affecting both
central and peripheral nervous system. Neurologic manifestations can be linked to viral …

Neurologic and neuromuscular sequelae of COVID-19

C Li, M Verduzco-Gutierrez - Physical Medicine and …, 2023 - pmr.theclinics.com
The impact of postacute sequelae of SARS-CoV-2 infection (PASC) on the central nervous
system (CNS) and peripheral nervous system (PNS) is widely known and can …